We asked Professor Antonio Almeida, the President of European Hematology Association about the benefits and perspectives in EHA as a European hematologist, about the highlights of this year EHA congress and about the new Guidelines.

Video: https://medicaldigest.org/scientific-contents/standalonecontent:haematology-forefront-interview-eha-president

Professor Vasilios Kotsis on obesity induced hypertension and its state of the art treatment.

Video: https://medicaldigest.org/scientific-contents/interview:obesity-induced-hypertension

Professor Roland Schmieder on the results of a prospective randomized sham-controlled study and explains the effects of renal denervation on blood pressure in patients with chronic kidney disease and uncontrolled hypertension

Video: https://medicaldigest.org/scientific-contents/interview:hypertension-and-beta-blocker-choice-influence-age-stress-and-co-morbidities

Professor Sverre Erik Kjeldsen at the recent annual meeting of the European Society of Hypertension, held a lecture on the role of beta-blockers in the management of hypertension.

Video: https://medicaldigest.org/scientific-contents/interview:hypertension-and-beta-blocker-choice-influence-age-stress-and-co-morbidities

Professor Konstantinos Tsioufis shares his thoughts on the novelties of kidney protection in hypertension.

Video:

Professor Francesca Mallamaci co-chaired a session at the current Annual Congress of the European Society of Hypertension on cardiovascular protective effects of SGLT-2 inhibitors. The new drug class revolutionized the treatment of type-2 diabetes. What did we learn in the clinical trials about these drugs regarding nephroprotection, CV protection in the diabetic population?

Video:

Professor Krzysztof Narkiewicz on why is it so difficult to reach the expected BP target in real-life patients.

Video: https://medicaldigest.org/scientific-contents/interview:why-it-so-difficult-reach-expected-bp-target-real-life-patients

Professor Bryan Williams chaired an interesting symposium at ESH 2024. The joint ESH/ESC guideline on the diagnosis and treatment of hypertension and explained his thoughts on how to improve adherence in hypertension management.

Video: https://medicaldigest.org/scientific-contents/interview:time-act-improve-adherence-hypertension-management-bridging-gap-between-knowledge-and-action

Professor Claudio Borghi chaired a symposium at ESH 2024 on two very important patient groups, diabetic patients and coronary patients, on antihypertensive treatment.

Video: https://medicaldigest.org/scientific-contents/interview:real-life-hypertensive-patients-towards-holistic-approach-clinical-practice

Professor Sofie Brouwers explained at ESH 2024 that antihypertensive treatment for chronic coronary artery disease should be based on an ACE inhibitor and the evidence supporting this.

Video: https://medicaldigest.org/scientific-contents/interview:hypertension-and-cad-need-more-spcs-report-esh2024